OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of AAV9-mediated SGPL1 gene transfer in a mouse model of S1P lyase insufficiency syndrome
Piming Zhao, Gizachew Tassew, Joanna Y. Lee, et al.
JCI Insight (2021) Vol. 6, Iss. 8
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Advances in mouse genetics for the study of human disease
Steve D. M. Brown
Human Molecular Genetics (2021) Vol. 30, Iss. R2, pp. R274-R284
Open Access | Times Cited: 39

Gene therapy with AAV9‐SGPL1 in an animal model of lung fibrosis
Aritra Bhattacharyya, Ranjha Khan, Joanna Y. Lee, et al.
The Journal of Pathology (2024) Vol. 263, Iss. 1, pp. 22-31
Open Access | Times Cited: 4

BDNF Modulation by microRNAs: An Update on the Experimental Evidence
Gilmara Gomes de Assis, Eugenia Murawska‐Ciałowicz
Cells (2024) Vol. 13, Iss. 10, pp. 880-880
Open Access | Times Cited: 4

Gene Editing: An Effective Tool for the Future Treatment of Kidney Disease
Meiling Cao, Ruirui Han, Shungen Chen, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 4001-4018
Open Access

Sphingosine phosphate lyase insufficiency syndrome: a systematic review
Zahra Pournasiri, Abbas Madani, Fatemeh Nazarpack, et al.
World Journal of Pediatrics (2022) Vol. 19, Iss. 5, pp. 425-437
Closed Access | Times Cited: 13

A rare cause of nephrotic syndrome—sphingosine-1-phosphate lyase (SGPL1) deficiency: 6 cases and a review of the literature
Tuğba Öztürk, Nur Canpolat, Seha Saygılı, et al.
Pediatric Nephrology (2022) Vol. 38, Iss. 3, pp. 711-719
Closed Access | Times Cited: 12

Current Status and Prospects of Viral Vector-Based Gene Therapy to Treat Kidney Diseases
Louise Medaer, Koenraad Veys, Rik Gijsbers
Human Gene Therapy (2024) Vol. 35, Iss. 5-6, pp. 139-150
Closed Access | Times Cited: 2

Factors influencing survival in sphingosine phosphate lyase insufficiency syndrome: a retrospective cross-sectional natural history study of 76 patients
Nancy P. Keller, Julian Midgley, Ehtesham Khalid, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2

Genotype/Phenotype Interactions and First Steps Toward Targeted Therapy for Sphingosine Phosphate Lyase Insufficiency Syndrome
Julie D. Saba, Nancy P. Keller, Jen‐Yeu Wang, et al.
Cell Biochemistry and Biophysics (2021) Vol. 79, Iss. 3, pp. 547-559
Closed Access | Times Cited: 13

A retrospective analysis of endocrine disease in sphingosine-1-phosphate lyase insufficiency: case series and literature review
Avinaash Maharaj, Ruth Kwong, Jack Williams, et al.
Endocrine Connections (2022) Vol. 11, Iss. 8
Open Access | Times Cited: 8

AAV-SPL 2.0, a Modified Adeno-Associated Virus Gene Therapy Agent for the Treatment of Sphingosine Phosphate Lyase Insufficiency Syndrome
Ranjha Khan, Babak Oskouian, Joanna Y. Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15560-15560
Open Access | Times Cited: 4

Targeted gene therapy for rare genetic kidney diseases
Veenita Khare, Stéphanie Cherqui
Kidney International (2024) Vol. 106, Iss. 6, pp. 1051-1061
Open Access | Times Cited: 1

Neurological Consequences of Sphingosine Phosphate Lyase Insufficiency
Krishan B. Atreya, Julie D. Saba
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 6

Mouse Liver Compensates Loss of Sgpl1 by Secretion of Sphingolipids into Blood and Bile
Anna Katharina Spohner, Katja Jakobi, Sandra Trautmann, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10617-10617
Open Access | Times Cited: 7

Prevalence estimate of sphingosine phosphate lyase insufficiency syndrome in worldwide and select populations
Joni C Sedillo, Chansonette Badduke, Steven J. Schrodi, et al.
Genetics in Medicine Open (2023) Vol. 2, pp. 100840-100840
Open Access | Times Cited: 2

Recent Advances in Proteinuric Kidney Disease/Nephrotic Syndrome: Lessons from Knockout/Transgenic Mouse Models
Ryosuke Saiki, Kan Katayama, Kaoru Dohi
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1803-1803
Open Access | Times Cited: 2

Outcomes of progranulin gene therapy in the retina are dependent on time and route of delivery
Emilia A. Zin, Daisy Han, Jennifer Tran, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 22, pp. 40-51
Open Access | Times Cited: 4

Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice
Anabel S. de la Garza-Rodea, Steven A. Moore, Jesus Zamora-Pineda, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7579-7579
Open Access | Times Cited: 3

Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome: A Retrospective Cross-Sectional Study of 76 Patients
Nancy P. Keller, Julian Midgley, Ehtesham Khalid, et al.
Research Square (Research Square) (2024)
Open Access

Phenotypic quantification of Nphs1-deficient mice
Ronen Schneider, Bshara Mansour, Caroline M. Kolvenbach, et al.
Journal of Nephrology (2024)
Closed Access

Sphingosine Phosphate Lyase Insufficiency Syndrome As a Primary Immunodeficiency State
Saber Gharagozlou, Nicola Wright, Luis Murguila-Favela, et al.
Advances in Biological Regulation (2024) Vol. 94, pp. 101058-101058
Open Access

Page 1 - Next Page

Scroll to top